MoneyWorks4Me

The sales for the March 2026 quarter moved up 33.49% to Rs. 1164.10 millions as compared to Rs. 872.06 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 222.95 millions  from Rs. 110.54 millions in the quarter ended March 2026.The company reported a good operating profit of 320.18 millions compared to 187.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1164.10 872.06 33.49 4527.66 3514.11 28.84 4527.66 3514.11 28.84
Other Income 51.63 45.30 13.97 633.88 614.90 3.09 633.88 614.90 3.09
PBIDT 320.18 187.00 71.22 1738.22 1321.69 31.51 1738.22 1321.69 31.51
Interest 0.60 0.77 -22.08 2.07 2.36 -12.29 2.07 2.36 -12.29
PBDT 319.58 186.23 71.61 1697.57 1319.33 28.67 1697.57 1319.33 28.67
Depreciation 31.15 31.14 0.03 120.83 114.05 5.94 120.83 114.05 5.94
PBT 288.43 155.09 85.98 1576.74 1205.28 30.82 1576.74 1205.28 30.82
TAX 65.48 44.55 46.98 258.68 181.08 42.85 258.68 181.08 42.85
Deferred Tax -2.22 9.10 -124.40 -12.01 12.22 -198.28 -12.01 12.22 -198.28
PAT 222.95 110.54 101.69 1318.06 1024.20 28.69 1318.06 1024.20 28.69
Equity 223.85 223.76 0.04 223.85 223.76 0.04 223.85 223.76 0.04
PBIDTM(%) 27.50 21.44 28.26 38.39 37.61 2.07 38.39 37.61 2.07
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..